Did the new French pay-for-performance system modify benzodiazepine prescribing practices?

Overview of attention for article published in BMC Health Services Research, July 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 23 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 31 X posts from 23 X users, with an upper bound of 298,234 followers.

RT @FrankMoriarty: Pay-for-performance for GPs not prescribing benzodiazepines for >12 wks? In France, resulted in switching from long- to…

28 Mar 2018

Reply Repost Favourite

RT @FrankMoriarty: Pay-for-performance for GPs not prescribing benzodiazepines for >12 wks? In France, resulted in switching from long- to…

28 Mar 2018

Reply Repost Favourite

Another #primarycare incentive fees disappointment. This one to stop prescribing dangerous drug. Didn’t work. @DrRFernandez @RuthLavergne @CaitO_PharmD https://t.co/OVgVO4auZ5

27 Mar 2018

Reply Repost Favourite

Pay-for-performance for GPs not prescribing benzodiazepines for >12 wks? In France, resulted in switching from long- to short-acting but more likely to be continued long-term #deRx2018 https://t.co/Rrb1EiLHTK

27 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 27 additional X posts.